Cellect Biotechnology appoints chief development officer
Insight Weekly: Loan delinquencies up; US money supply falls; coal employment grows
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Cellect Biotechnology Ltd. appointed Yaron Pereg chief development officer.
Pereg fills the role vacated by Nadir Askenasy, who resigned as chief technology officer.
Pereg worked as senior director of oncology at BioLineRx Ltd. and held research and development positions at Genentech Inc.
